Interaction Proteomics by Monti M. et al.
Interaction Proteomics
Maria Monti,1 Stefania Orru`,1 Daniela Pagnozzi,1 and Piero Pucci1,2
The term proteome is traditionally associated with the identiﬁcation of a large number of
proteins within complex mixtures originating from a given organelle, cell or even organism.
Current proteome investigations are basically focused on two major areas, expression
proteomics and functional proteomics. Both approaches rely on the fractionation of protein
mixtures essentially by two-dimensional polyacrylamide gel electrophoresis (2D-gel) and the
identiﬁcation of individual protein bands by mass spectrometric techniques (2D-MS).
Functional proteomics approaches are basically addressing two main targets, the elucidation
of the biological function of unknown proteins and the deﬁnition of cellular mechanisms at
the molecular level. In the cell many processes are governed not only by the relative
abundance of proteins but also by rapid and transient regulation of activity, association and
localization of proteins and protein complexes. The association of an unknown protein with
partners belonging to a speciﬁc protein complex involved in a particular process would then
be strongly suggestive of its biological function. The identiﬁcation of interacting proteins in
stable complexes in a cellular system is essentially achieved by aﬃnity-based procedures.
Diﬀerent strategies relying on this simple concept have been developed and a brief overview
of the main approaches presently used in functional proteomics studies is described.
KEY WORDS: Functional proteomics; mass spectrometry; protein–protein interactions;
aﬃnity-based strategies.
ABBREVIATIONS: 1D-gel: monodimensional gel electrophoresis; 2D-gel: two-dimensional
gel electrophoresis; AldA-NRE: Aldolase A negative regulatory element; ES-LC-MS/MS:
Electrospray Liquid Chromatography Tandem Mass Spectrometry; FCP1: TFIIF-associ-
ating component of CTD phosphatase; GST: Glutathione S-transferase; KRAB-ZFPs:
Kru¨ppel-like zinc-ﬁnger proteins; MALDI-MS: Matrix Assisted Laser Desorption Ioniza-
tion- Mass Spectrometry; MEP50: Methylosome protein 50; RNAPII-CTD: RNA Poly-
merase II – Carboxy Terminal Domain; SDS-PAGE: sodium dodecylphosphate
polyacrylamide gel electrophoresis; TAP: Tandem Aﬃnity Puriﬁcation; ZnF224: Zinc
Finger Protein 224.
INTRODUCTION
With the increase in the number of genome sequencing projects, there is a con-
comitant exponential growth in the number of protein sequences whose function is
still unknown. Biological sciences are currently experiencing a sort of paradoxal
1CEINGE Biotecnologie Avanzate s.c.a r.l. and Dipartimento di Chimica Organica e Biochimica, Uni-
versita` di Napoli Federico II, Complesso Universitario di Monte S. Angelo, via Cinthia 4, 80126 Napoli,
Italy.
2To whom correspondence should be addressed. E-mail: pucci@unina.it
Bioscience Reports, Vol. 25, Nos. 1/2, February/April 2005 ( 2005)
DOI: 10.1007/s10540-005-2847-z
45
0144-8463/05/0400-0045/0  2005 Springer Science+Business Media, Inc.
situation in which the protein sequence, the corresponding coding gene, its chro-
mosomic localization or even the regulation mechanisms may have been elucidated
but the biological role of the protein in the cell is still completely obscure.
The challenge has then shifted to identify and localize proteins within a given
organelle, cell or even organism as well as to unravel protein pathways in cellular
systems [1–8]. These new goals, however, cannot be easily achieved as intrinsic dif-
ﬁculties increase by several orders of magnitude when moving from genome to
proteome research. The static nature of the genome, in fact, cannot be compared to
the dynamic properties of the proteome; protein expressions proﬁles change several
times during the cell cycle and are heavily aﬀected by a number of intra- and
extracellular stimuli (temperature, stress, apoptotic signals, etc.) [1]. Moreover, the
occurrence of alternative splicing and post-translational modiﬁcations led to a
complete re-thinking of the old paradigm ‘‘one gene-one protein’’ that does not
reﬂect anymore the real nature of the cellular proteome.
Current proteome investigations are essentially focused on two major areas, the
expression proteomics, which aims to measure up-and down-regulation of protein
levels, and functional proteomics studies aimed at the characterisation of protein
activities, multiprotein complexes and signaling pathways [9–12]. Typically,
expression proteomics studies are investigating the expression protein patterns in
abnormal cells (i.e. malignant, stimulated by drug treatment, etc. . .) in comparison
to normal cells. In biomedical applications, this comparative approach is usually
employed to identify proteins that are up- or down-regulated in a disease speciﬁc
manner for use as diagnostic markers or therapeutic targets [13–16]. In these studies,
a reliable analysis of quantitative changes in protein expression is crucial. Such
changes are often obtained from the staining intensities of protein spots on gels, a
labor-intensive method that is prone to error. Recently, better and more reliable
results were achieved using stable isotope methodologies or dual ﬂuorescent tech-
niques [17–20].
Functional proteomics approaches are addressing two major topics, the eluci-
dation of biological function of unknown proteins and the deﬁnition of cellular
mechanisms at the molecular level. In the cells, many proteins display their biological
functions through the rapid and transient association within large protein complexes
[21]. Understanding protein functions as well as unraveling molecular mechanisms
within the cell is then depending on the identiﬁcation of the interacting protein
partners. The association of an unknown protein with partners belonging to a spe-
ciﬁc protein complex involved in a particular process would in fact be strongly
suggestive of its biological function [22, 23]. Furthermore, a detailed description of
the cellular signalling pathways might greatly beneﬁt from the elucidation of pro-
tein–protein interactions in the cell [24].
PROTEIN IDENTIFICATION BY MASS SPECTROMETRY
METHODOLOGIES
The key step in any proteomic study consists in the identiﬁcation of proteins
that have been either fractionated by gel electrophoresis or digested by enzymatic
procedures to generate peptide mixtures. Protein identiﬁcation from 1D or 2D
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gel-electrophoresis is obtained through peptide mass ﬁngerprinting essentially using
MALDI-MS (Fig. 1). After fractionation by electrophoresis, in the majority of the
cases, proteins are stained by colloidal Coomassie, excised from the gel and sub-
mitted to diﬀerent cycles of swelling and shrinking by alternate washing with
aqueous and organic solutions. Protein components are then reduced and alkylated
with iodoacetamide to irreversibly block the cysteine residues and digested in situ
with suitable amount of trypsin overnight. The resulting peptide mixture is extracted
from the gel by repeating the swelling/shrinking procedure and directly analysed by
MALDI-MS (using a reﬂectron instrument). Identiﬁcation of the various proteins is
carried out through the peptide mass ﬁngerprinting procedure: the mass values to-
gether with other information, such as the protease used for the hydrolysis and the
protein molecular mass roughly estimated from the SDS-PAGE gel, are introduced
into different mass search programs (e.g. ProFound, Mascot, MS-Fit, etc) available
on the net. The mass values are compared to those originating from the theoretical
digestion of all the proteins occurring in the database, leading to the identiﬁcation of
the protein(s).
Alternatively, when the mass ﬁngerprinting procedure is not sufﬁcient to
identify the proteins, electrospray ionization tandem mass spectrometry (ES-LC-
MS/MS) methods can be employed (Fig. 2). Peptide mixtures produced by in situ
digestions are fractionated by capillary HPLC analysis, the fractions eluted from
the column are directly inserted into the ES mass spectrometry source and their
mass values determined. Peptide ions will simultaneously be isolated and frag-
mented within the mass spectrometer, producing daughter ion spectra from which
Fig. 1. Outline of protein identiﬁcation strategy by peptide mass ﬁngerprinting.
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sequence information on individual peptides can be obtained. This information
together with the peptide mass values are then used to search for protein data-
bases, leading to the identiﬁcation of the protein components. It has been shown,
in fact, that sequence information from just two peptides is sufﬁcient to unam-
biguously identify a protein by searching protein and expressed sequence tag
databases.
IDENTIFICATION OF PROTEIN PARTNERS BY FUNCTIONAL
PROTEOMICS APPROACHES
It has become clear that a large number of proteins occur in protein complexes and
that understanding the function of a given protein within the cell necessitates identi-
ﬁcation of its interacting partners [25]. A key contribution to the identiﬁcation of
interacting proteins in stable complexes in cellular systems is provided by aﬃnity-based
approaches. The basic idea is to express the protein of interest with a suitable tag to be
used as a bait to ﬁsh its speciﬁc partners out from a cellular extract. Isolation of the
entire multi-protein complex can then be accomplished by taking advantage of the
availability of several anti-tag systems, immobilised on agarose–sepharose supports,
and showing high binding eﬃciency, as illustrated in Table 1 [26]. Diﬀerent strategies
relying on this simple concept have been developed and a brief overview of the main
approaches presently used in functional proteomics studies is described below.
Fig. 2. Schematic description of protein identiﬁcation performed by the LCMSMS approach.
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‘‘Fishing for Partners’’ Strategies
Recently, a new speciﬁc strategy was developed for the identiﬁcation of protein
partners interacting, even transiently, with a speciﬁc target, leading to an effective
alternative to molecular biology procedures based on the two-hybrid technique.
Using commercially available protein expression systems, the protein bait can be
produced as a hybrid protein fused to different tags, such as the Glutathione
S-transferase (GST-fused Protein), or small peptide epitopes i.e. FLAG, HA or
c-myc, or containing a poly-His tail or covalently modiﬁed with biotin [27]. In all
cases, the tagged bait can be immobilised onto agarose beads derivatised with the
appropriate anti-tag ligand (glutathione, anti-epitope antibodies, Nickel ions,
Streptavidin, etc.). All these aﬃnity tag systems provide a general applicability with a
large number of proteins and a minimal eﬀect on the tertiary structure and the
biological activity of the bait, preventing instability of complexes.
The entire cellular extract and/or, when appropriate, extracts from speciﬁc
organelles can then be incubated with the immobilised bait. The protein components
speciﬁcally recognised by the bait are retained while the unbound proteins are re-
moved by washing steps. The protein partners are successively eluted, fractionated
by SDS-PAGE, stained and then submitted to the mass spectrometry procedures for
protein identiﬁcation. An outline of this approach is shown in Fig. 3.
This strategy was applied to the identiﬁcation of the protein partners of
ZnF224, a zinc-ﬁnger protein of about 82 kDa belonging to the ‘‘Kru¨ppel-like’’
zinc-ﬁnger proteins family (KRAB-ZFPs), one of the largest classes of transcription
factors. This protein contains the box A (45 aa) of a Kru¨ppel-associated box
(KRAB) domain at the N-terminus, which is an evolutionarily conserved regulatory
domain and 19 Cys2Hys2 zinc-ﬁnger motifs at the C-terminus [28]. ZnF224 speciﬁ-
cally binds to the negative regulatory element (AldA-NRE) located in the promoter
region of the human aldolase A gene through its array of zinc-ﬁngers and inhibits the
transcription by the 45-amino-acid KRAB-A domain. The proteins interacting with
ZnF224 and involved in the transcriptional inhibition as well as the molecular
mechanisms of these negative regulation processes are still unknown. In order to
elucidate these aspects, the full-length cDNAs of ZnF224 and its deletion mutant
ZnF224-M1 containing only eight zinc-ﬁngers were expressed as fused protein to the
C-terminus of GST and puriﬁed on glutathione–sepharose resin. The puriﬁed chi-
meric bait was then linked to GSH-activated beads.
Table 1. Aﬃnity tags and ligands commonly used in the isolation of multiprotein
complexes
Tag Ligand
Poly-His Ni++
Biotin Streptavidin
Calmodulin-binding peptide Calmodulin (Ca++)
GST Glutathione
Speciﬁc Epitope
(FLAG, c-myc, HA, etc.) Monoclonal Ab
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Nuclear 293 cell extracts were pre-puriﬁed by incubation with GST-beads that
retained all the proteins unspeciﬁcally interacting with both the matrix and the GST
protein that would lead to false positives. The pre-cleaned extract was then incu-
bated with the GST–ZnF224 bait. After several washings to remove unbound pro-
teins, the complex components were eluted from the beads, separated by SDS-PAGE
and stained with Colloidal Coomassie (Fig. 4). Protein bands indicated by arrows
appeared to be present only in the sample and were then selected for identiﬁcation by
in situ digestion and LC-MS/MS analysis.
Although this approach has found large applications in the studies of protein–
protein interactions, a conspicuous number of drawbacks exists. The pre-cleaning
procedure allowed us to avoid the occurrence of an excessive background; however,
the presence of several identical bands in both the sample and the control and the
difﬁculties in identifying the proteins speciﬁcally interacting with the bait immedi-
ately underline the limitations of this procedure. Extensive pre-cleaning of the
extract is needed and a number of control samples have to be prepared. Cellular lysis
under hard conditions leads to the disruption of the architecture of subcellular
compartments thus generating non physiological interactions among proteins that
are normally segregated in different organelles. However, the major criticism to this
approach is that the interactions among the bait and its protein partners take place
in vitro on the derivatised beads and might not be indicative of functional interac-
tions. The overall effect of these drawbacks is the possible occurrence of false pos-
itives that should always be considered when using these procedures.
Fig. 3. Fishing for partners strategy.
50 Monti, Orru`, Pagnozzi, and Pucci
The success of an afﬁnity-based approach then depends on the absence of
excessive unspeciﬁc interactions that in turn is related to the speciﬁcity of the
bait-partners recognition. When this binding speciﬁcity is extremely high, as in the
case of DNA-binding proteins, a low levels of false positives is expected. In this
particular variant of the ﬁshing strategy, the bait consists of a speciﬁc oligonucleo-
tide linked to an insoluble support. Nuclear proteins can then be incubated with the
bait in search for speciﬁc partners, following the strategy outlined above [29].
Control experiments can easily be designed using randomised oligonucleotides. This
strategy was applied to the identiﬁcation of the transcriptional repressor that spe-
ciﬁcally binds to the human aldolase A (AldA) negative regulatory element (NRE).
This factor was eventually identiﬁed as the ZnF224 protein [28].
It should be underlined that when a putative candidate is identiﬁed by prote-
omic approaches, its identity has to be conﬁrmed by independent methodologies. In
the case of ZnF224, both the speciﬁcity of DNA sequence recognition and the
negative regulation of transcriptional activity of the AldolaseA gene had to be tested.
Therefore, the recombinant forms of wild type ZnF224 and two deletion mutants
were prepared and incubated with the AldANRE oligonucleotide region in a clas-
sical band shift experiment, demonstrating the ability of the wild type protein to
speciﬁcally recognise the DNA binding site. Moreover, a CAT reporter gene assay
was designed using the recombinant plasmid encoding ZNF224 and containing two
AldA-NRE core elements upstream of a heterologous basal promoter. The expressed
ZNF224 protein negatively modulated the reporter CAT gene transcription in a
Fig. 4. SDS-PAGE analysis of GST-ZnF224-M1 partners: lane M: markers; lane 1
proteins bound speciﬁcally to the protein bait; lane 2: second pre-cleaning on the
resin pre-incubated with GST alone; lane 3: ﬁrst pre-cleaning on the resin
pre-incubated with GST alone; lane 4: unbound proteins.
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dose-dependent manner, showing that ZnF224 was indeed able to repress the AldA-
NRE-mediated transcription of a heterologous promoter [26].
Immunoprecipitation Strategies
Alternative strategies essentially relying on immunoprecipitation techniques
have been introduced in order to overcome the major criticisms associated with the
ﬁshing procedure (Fig. 5) [30]. The gene coding for the bait tagged with an epitope
against which good antibodies exists (FLAG, HA, c-myc, etc.), is transfected into the
appropriate cell line and expressed in the cognate host. Protein complexes are al-
lowed to form and the cell extracts are immunoprecipitated with anti-tag mono-
clonal antibodies. The immunoprecipitated material containing the protein bait and
its interacting partners can then be fractionated by SDS-PAGE and the individual
protein components identiﬁed by diﬀerent mass spectrometric methodologies.
The immunoprecipitation strategy was employed to identify the protein part-
ners of FCP1, a conserved phosphatase involved in the regulation of eukaryotic
RNA polymerase II [31]. In order to elucidate the role of FCP1, identiﬁcation of
FCP1 associating factors using a 3 · FLAG-tagged FCP1 stably expressing cell line
was performed [32]. Following complex formation, nuclear extracts were immuno-
precipitated with anti-FLAG agarose-conjugated antibody. The protein bands sep-
arated on SDS-PAGE and stained by colloidal Coomassie were identiﬁed essentially
by mass ﬁngerprinting. Among several other speciﬁc FCP1 partners, the methylo-
Fig. 5. Outline of the immunoprecipitation strategy.
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some protein 50, MEP50, was identiﬁed. However, this protein belongs to a cytosolic
complex whereas FCP1 was exclusively found in the nucleus, thus making this
identiﬁcation questionable. Independent veriﬁcation experiments were then de-
signed, including co-immunoprecipitation of FLAG-FCP1 and a recombinant form
of MEP50 containing a c-myc-tag and sub-cellular localization by both sedimenta-
tion proﬁling and immunoﬂuorescence techniques. The results obtained demon-
strated that MEP50 and FCP1 associate into the nucleus in a complex of the same
size distinct from the 20S methylosome complex and that FCP1 is able to interact
with components of the pre-mRNA spliceosomal complex. These ﬁndings add fur-
ther support to the concept that there is functional intercommunication between the
transcription and splicing machineries, and the RNAPII-CTD appears to play a
pivotal role in coordinating transcription and pre-mRNA processing [32, 33 and
references therein].
Although the immunoprecipitation approach seems to provide signiﬁcant data
in most of the cases, some drawbacks need to be discussed. Antibodies used in
immunostaining methods are not always suitable for immunoprecipitation protocols
that require a more efﬁcient (and quantitative) recognition of the proper antigen
compared to Western blotting or ELISA applications. Cross-reaction with unspeciﬁc
antigens or unspeciﬁc binding of proteins to the antibodies, to the peptide tags or to
the insoluble support can lead to false positives. Pre-cleaning of the cellular extract
with antibodies of the animal host not yet immunised against the speciﬁc antigen is
then strongly suggested.
Recently a debated question arose concerning the use of antibodies speciﬁcally
directed against the protein bait; this antibody might compete with the interacting
proteins for binding to bait epitopes thus leading to destabilization of protein–
protein interactions and dissociation of the complexes, at least partially. These
problems have been overcome by using tagged proteins although the presence of the
tag might affect protein conformation, altering or impairing complex formation. A
ﬁrst clue to solve this issue comes from preliminary experiments carried out on
protein baits tagged at either the N- or the C-terminus; moreover, the three
dimensional structure of the bait, when available, should carefully be considered to
decide where the tag should be posed. Finally, overexpression of the tagged protein
in the host cells should deﬁnitely be avoided since a high concentration of the bait
alters the stoichiometric ratio with its natural partners often leading to the formation
of nonspeciﬁc and/or nonnatural protein interactions with host proteins [34].
The Tap Tag System
The tandem afﬁnity puriﬁcation (TAP) tag system was developed for the
puriﬁcation of protein complexes in high yield under native conditions [35]. In this
procedure, two diﬀerent tags usually separated by an enzyme-cleavable linker se-
quence are inserted on the same protein and the protein complexes are puriﬁed by
two aﬃnity puriﬁcation steps. The ﬁrst proposed TAP tag system consisted of two
IgG binding domains of Staphylococcus aureus protein A (ProtA) and a calmodulin
binding peptide (CBP) separated by a TEV protease cleavage site (Fig. 6) [36]. This
system is very ﬂexible and variations to the original strategy, including application of
the tag cassette to either the N- or the C-terminal end of the protein, the introduction
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of alternative tags and the tailoring of the system for various host organisms can
easily be obtained.
The TAP tags are introduced in-frame with the coding region of the protein bait
in an appropriate expression vector using standard DNA cloning procedures. The
tagged construct can then be transiently or stably introduced into recipient cells or
organisms. Optimally, the recombinant vector should replace the endogenous
wild-type gene, although this condition might not always be possible. In all cases,
overexpression of the protein bait is avoided since the TAP tag system was speciﬁ-
cally designed for recovery of protein complexes expressed at their own natural level.
The ﬁrst afﬁnity puriﬁcation step of the native complex consists in the binding of
ProtA to an IgG matrix. Elution of the bound material under native conditions is
achieved by using the TEV protease and the eluate of this ﬁrst afﬁnity step is then
incubated with calmodulin-coated beads in the presence of calcium. Nonspeciﬁc
protein contaminants and the excess of TEV protease are removed by repetitive
washing and the bound material is released under mild conditions by elution with
EGTA. Individual protein components of the eluted complex can then be fractionated
by SDS-PAGE and identiﬁed by different mass spectrometric methodologies.
This puriﬁcation procedure based on a double afﬁnity step signiﬁcantly reduces
the possible occurrence of nonspeciﬁc protein contaminants, thus decreasing both
the unspeciﬁc background noise on the SDS gel and the possible presence of false
positives. This method was originally developed in yeast [36] and has been found
widespread use for the description of multiprotein complexes in Saccharomices
cerevisiae [22]. However, optimized conditions have been developed for the generic
use of the TAP strategy. Recently the system has been successfully optimized even in
Fig. 6. Schematic representation of the TAP-Tag strategy.
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mammalian cells [37] by using alternative tags to further reduce unspeciﬁc interac-
tions between tags and extract proteins [38].
CONCLUSIONS AND PERSPECTIVES
With the increasing number of genome sequencing projects coming to a suc-
cessful end, understanding protein function and unraveling cellular mechanisms at
the molecular level constitute today a major need in modern biology. These goals can
be achieved by determining which macromolecules interact with a given protein in a
speciﬁc manner. For the ﬁrst time, we have the possibility to deﬁne the transient
formation of functional protein complexes or to describe signal transduction path-
ways just as the scientists in the early ’30s were able to describe ‘‘step by step’’ the
metabolic pathways. The functional proteomic approaches described in this paper
have proven to be useful tools for the detection of interacting partners of a target
protein, although each of them highlighted the occurrence of possible drawbacks.
Particular attention should be paid to false positives which might result in misleading
interpretations; improvements and reﬁning of the afﬁnity-based procedures are
needed to take care of this aspect. A further factor that should carefully be con-
sidered is the dynamics of the formation and dissociation of protein complexes.
Proteins assemble at the right place and the right time to fulﬁll a speciﬁc function;
complexes then dissociate and individual components can participate in the for-
mation of other complexes, following the occurrence of speciﬁc signals.
Future aims of proteomic investigations will need to address the transfer of
these approaches to an in vivo system by generating animal models bearing a tagged
form of the given protein. If vital animals are obtained, homozygous embryos will
then provide tissues and/or progenitor cells for immunoprecipitation assays. Pro-
teomic analyses of the protein complexes occurring in vivo will disclose the identity of
the individual components and whether they differ from a territory to another.
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